Instructional Video

Hhmi: Biointeractive: Gleevec Inhibits Cancer Causing Kinase Bcr Abl

Curated by ACT

See the drug Gleevec in action as it binds to and inactivates BCR-ABL, a mutant kinase that causes chronic myeloid leukemia. [3:31]

3 Views 0 Downloads